Long-term administration of omeprazole in mice: a study of behavior, inflammatory, and oxidative stress alterations with focus on central nervous system.

[1]  Wenwen Xu,et al.  Investigation into the Impact of Proton Pump Inhibitors on Sertraline Transport across the Blood-Brain Barrier. , 2023, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  M. Kandasamy,et al.  Omeprazole treatment manifests anxiolytic effects in a cysteamine hydrochloride induced mouse model of gastrointestinal disorder , 2022, Heliyon.

[3]  F. Ciruela,et al.  Inhibition of Tryptophan Hydroxylases and Monoamine Oxidase-A by the Proton Pump Inhibitor, Omeprazole—In Vitro and In Vivo Investigations , 2020, Frontiers in Pharmacology.

[4]  M. Choudhary,et al.  Elevated anxiety, hypoactivity, memory deficits, decreases of brain serotonin and 5-HT-1A receptors expression in rats treated with omeprazole , 2020, Toxicological Research.

[5]  V. Giridharan,et al.  The role of the microbiota-gut-brain axis in neuropsychiatric disorders , 2020, Revista brasileira de psiquiatria.

[6]  Jung-Soo Han,et al.  Recognition memory impairments and amyloid-beta deposition of the retrosplenial cortex at the early stage of 5XFAD mice , 2020, Physiology & Behavior.

[7]  S. Imoto,et al.  Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in mice , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[8]  A. Kurilshikov,et al.  Impact of commonly used drugs on the composition and metabolic function of the gut microbiota , 2020, Nature Communications.

[9]  Z. Lorigooini,et al.  Trigonelline through the Attenuation of Oxidative Stress Exerts Antidepressant- and Anxiolytic-Like Effects in a Mouse Model of Maternal Separation Stress , 2019, Pharmacology.

[10]  L. Teh,et al.  Effects of proton pump inhibitor on the human gut microbiome profile in multi-ethnic groups in Singapore. , 2019, Singapore medical journal.

[11]  Chandragouda R. Patil,et al.  Protective effect of omeprazole and lansoprazole on β-receptor stimulated myocardial infarction in Wistar rats , 2019, Molecular and Cellular Biochemistry.

[12]  Mohammad Safiqul Islam,et al.  Elevated serum levels of malondialdehyde and cortisol are associated with major depressive disorder: A case-control study , 2018, SAGE open medicine.

[13]  C. Charitos,et al.  Hyperpyrexia in a patient with a left ventricular assist device: a diagnosis beyond the obvious. , 2018, Interactive Cardiovascular and Thoracic Surgery.

[14]  P. Crane,et al.  Proton Pump Inhibitor Use and Dementia Risk: Prospective Population‐Based Study , 2018, Journal of the American Geriatrics Society.

[15]  Cheng-Ta Li,et al.  Use of Proton Pump Inhibitors and Risk of Major Depressive Disorder: A Nationwide Population-Based Study , 2018, Psychotherapy and Psychosomatics.

[16]  Andrzej Pilc,et al.  The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  B. Gürer,et al.  The Protective Effect of Omeprazole Against Traumatic Brain Injury: An Experimental Study. , 2017, World neurosurgery.

[18]  E. Epel,et al.  Oxidative stress, inflammation and treatment response in major depression , 2017, Psychoneuroendocrinology.

[19]  Chandragouda R. Patil,et al.  In vivo and in vitro protective effects of omeprazole against neuropathic pain , 2016, Scientific Reports.

[20]  S. Chattarji,et al.  Early hippocampal volume loss as a marker of eventual memory deficits caused by repeated stress , 2016, Scientific Reports.

[21]  A. Rubartelli,et al.  Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance , 2016, Cell Death and Disease.

[22]  Karl Broich,et al.  Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis. , 2016, JAMA neurology.

[23]  S. Sands,et al.  The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice , 2014, BMC Research Notes.

[24]  T. Shibamoto,et al.  Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model. , 2014, Nutrition research.

[25]  I. Bernátová,et al.  Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide , 2013, Interdisciplinary toxicology.

[26]  M. Gorbien,et al.  Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities. , 2013, Journal of the American Medical Directors Association.

[27]  Patrick Aloy,et al.  The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production , 2013, PloS one.

[28]  V. Jain,et al.  Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase , 2008, Alimentary pharmacology & therapeutics.

[29]  M. Namazi,et al.  A succinct review of the general and immunological pharmacologic effects of proton pump inhibitors , 2008, Journal of clinical pharmacy and therapeutics.

[30]  Nihal Ahmad,et al.  Dose translation from animal to human studies revisited , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  Y. Ergün,et al.  Prevention of pro-depressant effect of L-arginine in the forced swim test by NG-nitro-L-arginine and [1H-[1,2,4]Oxadiazole[4,3-a]quinoxalin-1-one]. , 2007, European journal of pharmacology.

[32]  R. Hunt,et al.  Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. , 2001, Best practice & research. Clinical gastroenterology.

[33]  S R Tannenbaum,et al.  Nitrate biosynthesis in man. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Chen,et al.  Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. , 2001, Scandinavian journal of gastroenterology.

[35]  D. Charney,et al.  The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. , 1996, Pharmacopsychiatry.

[36]  D. Janero,et al.  Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. , 1990, Free radical biology & medicine.